SAN DIEGO, April 10, 2026 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the company will attend multiple upcoming investor conferences.
Read more at prnewswire.com
Viking Therapeutics to Participate at Upcoming Investor Conferences
Provided By PR Newswire – Last update: